Simtra BioPharma Solutions Announces Strategic Purchase to Expand US Manufacturing Capacity for Injectable Medicines

URLhttps://drug-dev.com/simtra-biopharma-solutions-an
Sourcedrug-dev.com
Date Published07/01/2025

Additional Reshoring Information:

Company/Division name Simtra BioPharma Solutions
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2025
Domestically, the work will be done:In-house
Capital investment ($):250
City reshored to:Bloomington
State(s) reshored to:IN
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredoncology treatments
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
Find Reshoring Articles